Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myoglobin is a monomeric, heme-containing protein primarily located in the cardiac and skeletal muscle of vertebrates [1, 8]. Its primary biological role is to store oxygen and facilitate its diffusion to mitochondria, thereby supporting aerobic metabolism during muscle contraction [8, 12]. Beyond oxygen transport, myoglobin acts as a scavenger of nitric oxide (NO) and reactive oxygen species (ROS), and it can function as a nitrite reductase under hypoxic conditions to produce NO and regulate vasodilation [11, 17]. Clinically, myoglobin is a critical biomarker; its release into the bloodstream following muscle injury (rhabdomyolysis) or myocardial infarction serves as an early indicator of tissue damage [2, 9]. However, elevated systemic myoglobin is a potent protoxin that can cause acute kidney injury through the induction of oxidative stress and direct toxic effects on renal tubular cells [8, 16]. While not a traditional therapeutic target for drugs, its levels are monitored to assess the safety and efficacy of treatments for muscle and heart conditions [7, 9].
Not applicable; myoglobin is primarily a biomarker and protoxin rather than a therapeutic drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myoglobin (MB) (MB).